$125 | Single User
$250 | Site License
$375 | Enterprise License

Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review
[Published by Global Data]

Published by Global Data: 26 Jul 2016 | 13448 | In Stock
Related Topics: Abbott

Introduction

Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott India Limited (Abbott India), a subsidiary of Abbott Laboratories, is a pharmaceutical company that discovers, develops, manufactures and markets branded generic pharmaceuticals, diagnostics, medical devices and nutritionals. Its product portfolio encompasses multi-specialty drugs, vitamins and a comprehensive range of products for the treatment of hypothyroidism, vertigo, epilepsy, depression and migraine. The company’s offerings also include vaccines for influenza, typhoid and diarrhea. Abbott India develops pharmaceuticals in various formulations including tablets, liquids, injectibles and capsules. Its product range helps treat gynecological, gastroenterological, urological and neurological diseases, diabetes, pain and infection. The company has operations all over India. Abbott India is headquartered in Mumbai, Maharashtra, India.

Abbott India Limited Key Recent Developments

Mar 14, 2016: India bans over 350 fixed dose combination drugs

Feb 29, 2016: Change in Directors : Abbott India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    Abbott India Limited - Key Facts 6

    Abbott India Limited - Key Employees 7

    Abbott India Limited - Key Employee Biographies 8

    Abbott India Limited - Major Products and Services 9

    Abbott India Limited - History 11

    Abbott India Limited - Company Statement 13

    Abbott India Limited - Locations And Subsidiaries 14

    Head Office 14

    Other Locations & Subsidiaries 14

    Section 2 – Company Analysis 15

    Abbott India Limited - Business Description 15

    Abbott India Limited - Corporate Strategy 16

    Abbott India Limited - SWOT Analysis 17

    SWOT Analysis - Overview 17

    Abbott India Limited - Strengths 17

    Strength - Research and Development (R&D) Activities 17

    Strength - Enhanced Performance across Business Divisions 17

    Strength - Leading Brands 17

    Abbott India Limited - Weaknesses 18

    Weakness - Fixed Dose Combination (FDC) Drugs 18

    Abbott India Limited - Opportunities 19

    Opportunity - Organic Growth Strategy: Expanded Product Portfolio 19

    Opportunity - Key Initiatives 19

    Opportunity - Growth Prospects: Indian Pharmaceuticals Market (IPM) 19

    Abbott India Limited - Threats 20

    Threat - Stringent Regulatory Standards 20

    Threat - Intense Competition 20

    Threat - Rapid Technological Changes 20

    Abbott India Limited - Key Competitors 21

    Section 3 – Company Financial Ratios 22

    Financial Ratios - Capital Market Ratios 22

    Financial Ratios - Annual Ratios 23

    Performance Chart 24

    Financial Performance 24

    Financial Ratios - Interim Ratios 25

    Financial Ratios - Ratio Charts 26

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 27

    Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

    Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28

    Abbott India Limited, Recent Deals Summary 29

    Section 5 – Company’s Recent Developments 30

    Mar 14, 2016: India bans over 350 fixed dose combination drugs 30

    Feb 29, 2016: Change in Directors : Abbott India 31

    Feb 29, 2016: Change in Directors : Abbott India 32

    Section 6 – Appendix 33

    Methodology 33

    Ratio Definitions 33

    About GlobalData 37

    Contact Us 37

    Disclaimer 37

List Of Tables
in Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Tables

Abbott India Limited, Key Facts 6

Abbott India Limited, Key Employees 7

Abbott India Limited, Key Employee Biographies 8

Abbott India Limited, Major Products and Services 9

Abbott India Limited, History 11

Abbott India Limited, Other Locations 14

Abbott India Limited, Key Competitors 21

Abbott India Limited, Ratios based on current share price 22

Abbott India Limited, Annual Ratios 23

Abbott India Limited, Interim Ratios 25

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28

Abbott India Limited, Recent Deals Summary 29

Currency Codes 33

Capital Market Ratios 33

Equity Ratios 34

Profitability Ratios 34

Cost Ratios 35

Liquidity Ratios 35

Leverage Ratios 36

Efficiency Ratios 36

List Of Figures, Charts and Diagrams
in Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Figures

Abbott India Limited, Performance Chart (2012 - 2016) 24

Abbott India Limited, Ratio Charts 26

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

Abbott India Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 28

Additional Details

Publisher

Global Data

Publisher Information

Reference

13448 | GDPH80379FSA

Number of Pages

37

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Abbott Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update
SummaryAbbott Vascular Inc. (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Labor...
30 Mar 2016 by Global Data USD $750 More Info
Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
09 Mar 2016 by Global Data USD $250 More Info
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth st...
07 Mar 2016 by Global Data USD $125 More Info
Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
24 Feb 2016 by Global Data USD $250 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC), formerly TheraSense, Inc. a subsidiary of Abbott Laboratori...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical di...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into t...
11 Jan 2016 by Global Data USD $125 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC)formerly known as TheraSense, Inc., discovers, develops, manu...
15 Oct 2015 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott) is a medical diagnostic company. The company provides molecula...
15 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...